Sullivan & Worcester advised DarioHealth on the deal. DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced it has entered into an...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here